PRE: נכסי החברה Prenetics Global Ltd

Prenetics Global dominates the DNA diagnostics sector, serving individuals and businesses worldwide. The company minimizes risks through home testing and a network of laboratories, creating sustainable demand. The business relies on the defensive medical innovation sector, which remains independent of macroeconomic trends. The market valuation dynamics, which have reached the level of 169.62, confirm these fundamental indicators.

Prenetics Global (PRE) transition to long-term IT solutions in DNA screening requires a reassessment of its resource base. This metric, reverse-engineered via ROA, determines the total value of controlled resources to evaluate financial stability. It is critical for investors to correlate capital volume with efficiency to mitigate the risk of low turnover. By analyzing the trajectory of total assets (via ROA), one can assess the company's ability to sustain its new business model.